Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Dynamic Learning in Depression

15. juni 2020 oppdatert av: University of Oxford
This study will assess learning bias (the tendency to learn more from negative relative to positive outcomes) at baseline in 3 groups of participants (currently depressed, previously depressed and never depressed). It will then try to modify this bias using a simple computerised training task completed at home daily for 2 weeks. Outcome measures include symptoms of depression, cognitive measures (i.e. accuracy and reaction time during completion of tasks), pupillometry measures and salivary cortisol.

Studieoversikt

Status

Fullført

Forhold

Detaljert beskrivelse

Depressed patients tend to focus on negative, at the expense of positive, events. This bias of attention is thought to be one factor which causes some people to be at higher risk of developing depression. One reason depressed people might pay more attention to negative events is that they think those events are more useful to them when they learn about the future. In this study the investigators will compare the learning styles (i.e. whether participants focus more on negative or positive information when learning about the future), cognitive biases and salivary cortisol levels (the levels of the hormone cortisol can be measured in the saliva and is known to be raised in those at risk of depression) of currently depressed (N=40), previously depressed (N=40) and never depressed (N=40) participants. The study will then randomly assign participants to complete one of two version of a learning task daily over two weeks. One version of the task will be designed to encourage an optimistic learning style, whereas the other will encourage neither an optimistic nor pessimistic learning style. The study will then retest participants' learning styles, cognitive biases, salivary cortisol and mood (using questionnaire measures) after completion of the task and again after 1 month. Study activities for participants will be: Screening visit (1 hours), baseline test visit (2 hours), task completion at home (10 mins per day for 2 weeks), test visit 2 (2 hours, completed 2 weeks after baseline visit) and test visit 3 (2 hours, completed 1 month after test visit 2). Participants will be asked to collect saliva samples, to measure cortisol, immediately after they wake up on the 3 testing days. Note that testing sessions involve pupillometry (measurement of area of pupil of the eye). This is done using a specialised camera pointed at the eye and is not invasive.

Studietype

Intervensjonell

Registrering (Faktiske)

120

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Oxfordshire
      • Oxford, Oxfordshire, Storbritannia, OX3 7JX
        • Dept of Psychiatry, University of Oxford

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 60 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 to 60 years.
  • Fluent in English.
  • Not currently taking any psychoactive medications (except hormone contraceptives).
  • Currently meets SCID (Structured Clinical Interview for Diagnosis:DSMV) criteria for MDD--Major Depressive Disorder-- (currently depressed group only).
  • Meets SCID criteria for 2 or more previous episodes of MDD, has been in remission for at least 3 months (previously depressed group only).
  • No previous or current axis I diagnosis (control group only).

Exclusion Criteria:

  • Previous or current diagnosis of bipolar disorder or psychotic illness.
  • Previous or current anxiety disorder (control group only, anxiety disorder is permitted in current and previously depressed group as long as primary diagnosis of MDD (current or previous) is present).
  • Significant suicidal ideation.
  • Use of drug of abuse within the last 3 months.
  • Receiving treatment (either pharmacological or psychological) for psychiatric condition.
  • Medical or surgical treatment which prevents dilation/constriction of pupil.
  • Prior experience of the tasks used in the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: IBLT (information bias learning task)
Computerised task in which most information is provided by positive outcomes. Completed for 10 mins per day every day for 2 weeks.
Information bias learning task-- a computer based task in which positive information is more useful when learning how best to complete it
Placebo komparator: IBLT control
Computerised task in which information is provided by both positive and negative outcomes. Completed 10 mins per day every day for 2 weeks
A control version of the IBLT task-- a computer based task in which both positive and negative information is useful when learning how to complete it

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Quick Inventory of Depressive Symptoms (self report, 16 item)
Tidsramme: change between baseline and week 6
Standard questionnaire measure of depressive symptoms
change between baseline and week 6

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Quick Inventory of Depressive Symptoms (self report, 16 item)
Tidsramme: change between baseline and week 2
standard questionnaire measure of depressive symptoms
change between baseline and week 2
Montgomery Asberg Depression Rating Scale
Tidsramme: change from baseline to week 2 and 6
Standard clinical rating scale for depression
change from baseline to week 2 and 6
Learning parameters from information bias assessment task
Tidsramme: baseline to weeks 2 and 6
Derived parameters from a computer based learning task (tests process presumed to be altered by IBLT-- information bias learning task-- intervention)
baseline to weeks 2 and 6
Salivary cortisol concentration
Tidsramme: baseline to weeks 2 and 6
Samples collected on waking
baseline to weeks 2 and 6
Learning parameters derived from pupillometry data
Tidsramme: baseline to weeks 2 and 6
Parameters are derived from regression of pupil size data collected during the information bias assessment task
baseline to weeks 2 and 6

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Speilberger State and Trait Anxiety Inventory
Tidsramme: Baseline to weeks 2 and 6
standard questionnaire measure of state and trait anxiety
Baseline to weeks 2 and 6
Depressive Attributes Questionnaire
Tidsramme: baseline to weeks 2 and 6
Questionnaire assessing attribution bias in depression
baseline to weeks 2 and 6
Rumination Response Scale
Tidsramme: baseline to weeks 2 and 6
Questionnaire assessing tendency to ruminate
baseline to weeks 2 and 6
Snaith-Hamilton Pleasures Scale
Tidsramme: Baseline to weeks 2 and 6
Questionnaire assessing anhedonia
Baseline to weeks 2 and 6
Accuracy and reaction time during computerised cognitive tasks
Tidsramme: baseline to weeks 2 and 6
Scores are derived from computer based tasks assessing emotional perception and learning
baseline to weeks 2 and 6

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Michael Browning, MB.BS, University of Oxford

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. november 2016

Primær fullføring (Faktiske)

3. juni 2020

Studiet fullført (Faktiske)

3. juni 2020

Datoer for studieregistrering

Først innsendt

22. september 2016

Først innsendt som oppfylte QC-kriteriene

22. september 2016

Først lagt ut (Anslag)

26. september 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. juni 2020

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. juni 2020

Sist bekreftet

1. april 2019

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • Dynamic Learning in Depression

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Anonymised data will be shared with researchers who contact the PI after study completion.

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere